Impact of Different Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blocker Resumption Timing on Post Acute Kidney Injury Outcomes
Our cohort demonstrates lower risks for mortality, cardiovascular events, and ESRD with early ACEI/ARB resumption, without heightened risks of severe hyperkalemia or rehospitalization for AKI. Early resumption should be considered for patients with indications for ACEI/ARB.
Authors
- Jia‐Jin Chen (ORCID: https://orcid.org/0000-0001-9508-5956)
- Ming‐Jen Chan (ORCID: https://orcid.org/0000-0003-1482-8557)
- Tsung-Yu Tsai
- Cheng‐Chia Lee (ORCID: https://orcid.org/0000-0002-6973-5908)
- Pei‐Chun Fan (ORCID: https://orcid.org/0000-0003-2974-249X)
- Chih‐Hsiang Chang (ORCID: https://orcid.org/0000-0002-7342-335X)
- Chieh‐Li Yen (ORCID: https://orcid.org/0000-0002-7293-0149)
- Yung‐Chang Chen (ORCID: https://orcid.org/0000-0003-3062-8467)
- Chih-Wei Yang
Institutions
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
- Linkou Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2024-08-31
- DOI
- https://doi.org/10.1016/j.ekir.2024.08.027
- Citations
- 4
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 1.36
Funders
- Clinical Trial Center, China Medical University Hospital
- Chang Gung Medical Foundation
- Chang Gung Memorial Hospital, Linkou